BioSpace News Archive

Vallon Pharmaceuticals Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs that are designed to deter abuse in the treatment of central nervous system (CNS) disorders, today announced that the European Patent Office has issued patent number EP3576719B1 covering ADAIR1

ExCellThera Inc. (ExCellThera), a clinical-stage molecular medicine company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, today announced that it has entered into a licensing agreement with Astellas Pharma Inc. through its US subsidiary, Astellas Institute for Regenerative Medicine

The CATS®-D Disposable Prism, designed to deliver improved intraocular pressure (IOP) measurement accuracy using a sterile, disposable tip replacement for the Goldmann Tonometer, received FDA clearance and will be available for sale fall 2021.

Suono Bio, Inc. today announced it has raised an $8.5 million Series A financing led by Axil Capital and Mizuho Securities Principal Investment, with participation by Taiwania Capital and other investors.

Unicycive Therapeutics, Inc. today announced the pricing of its underwritten initial public offering of 5,000,000 units at a public offering price per unit of $5.00 .

- Kelly Gold promoted to Chief Business Officer and SVP, Finance - Michelle Gates appointed SVP, Chief People Officer - Ravi Thadhani, M.D., M.P.H. named to board of directors

Neovasc Team Grows with Addition of Industry Veterans Lisa Becker as VP, Regulatory Affairs, Global Angina Therapies and Sarah Gallagher as VP of Clinical Affairs.

Ambry Genetics Corporation (Ambry), a Konica Minolta Precision Medicine (KMPM) company and leader in clinical diagnostic testing, has been the leading organization in contributions to The Gene Curation Coalition (GenCC) Database since its launch in December 2020.

Positive Results from Phase 2 Presbyopia (VEGA-1) and Phase 3 Reversal of Mydriasis (MIRA-2) Studies to be Presented at 2021 ASCRS Annual Meeting in Las Vegas

NeuroLogica Corp. announced that its state-of-the-art, OmniTom Elite with Photon Counting Detector technology will be piloted by Massachusetts General Hospital, bringing multi-energy computed tomography imaging to the patient’s point-of-care.